Capital Flow Monitor · Sponsors · CIK 2015545
Decheng Capital Global Life Sciences Fund V, L.P.
C/O MAPLES CORPORATE SERVICES LIMITED, GRAND CAYMAN, E9, KY1-1104 · 345-949-8066
Pooled Investment Fund / Venture Capital Fund · Other· inc. CAYMAN ISLANDS true 2024
Fit score
—
Offering
$700.0M
Sold
$452.0M
% sold
64.6%
Investors
42
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-10-03 | D/A ·current | 506(b) | $700.0M | $452.0M | 64.6% | 42 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Xiangmin Cui — Director, Grand Cayman, E9
3 other raises
- Baylor Genetics Holdings, Inc. $50.0M of $100.0M · 50.0%
- Decheng Capital Global Healthcare Fund, LP $139.0M of —
- Decheng Capital Global Healthcare Fund (Offshore), LP $33.1M of —
- Yuheng Qiu — Director, Grand Cayman, E9
- N/A N/A Decheng Capital Management V (Cayman), LLC — Promoter, Grand Cayman, E9
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.